The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Cytori Therapeutics Inc

Nasdaq: CYTX
Last

(U.S.) $2.01

Today's change0.00 0.00%
Updated September 29 4:00 PM -4GMT. Delayed by at least 15 minutes.
 

Cytori Therapeutics Inc

Nasdaq: CYTX
Last

(U.S.) $2.01

Today's change0.00 0.00%
Updated September 29 4:00 PM -4GMT. Delayed by at least 15 minutes.

Cytori Therapeutics Inc closed at (U.S.)$2.01.

Over the last five days, shares have lost 3.83% and are down 27.57% for the last year to date. This security has underperformed the S&P 500 by 73.54% during the last year.

Key company metrics

  • Open(U.S.) $2.08
  • Previous close(U.S.) $2.01
  • High(U.S.) $2.08
  • Low(U.S.) $2.00
  • Bid / Ask(U.S.) $0.00 / (U.S.) $2.68
  • YTD % change-27.57%
  • Volume64,501
  • Average volume (10-day)121,642
  • Average volume (1-month)121,426
  • Average volume (3-month)161,543
  • 52-week range(U.S.) $1.81 to (U.S.) $6.45
  • Beta2.67
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.91
Updated September 29 4:00 PM -4GMT. Delayed by at least 15 minutes.
S&P TSX0.16%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue3332
Total other revenue--------
Total revenue3332
Gross profit2232
Total cost of revenue1111
Total operating expense9850
Selling / general / administrative3333
Research & development5454
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)0000
Other operating expenses, total--------
Operating income-6-5-22
Interest income (expense), net non-operating-1-1-1-1
Gain (loss) on sale of assets0000
Other--------
Income before tax-6-5-32
Income after tax-6-5-32
Income tax, total--------
Net income-6-5-32
Total adjustments to net income0000
Net income before extra. items-6-5-32
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-6-5-32
Inc. avail. to common incl. extra. items-6-5-32
Diluted net income-6-5-32
Dilution adjustment--------
Diluted weighted average shares15141111
Diluted EPS excluding extraordinary itemsvalue per share-0.43-0.37-0.250.14
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.43-0.37-0.250.15